Protagenic Therapeutics, Inc.
PTIX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001022899
In the last 90 days, Protagenic Therapeutics, Inc. insiders filed 7 open-market purchases and 0 sales; 2 institutions reported holding it in 13F filings for Q2 2026, worth $25.4K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Protagenic Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 11 | 11 | 0 |
| Shares | 70.6K | 100.4K | +29.8K (+42.2%) |
| Value | $258.1K | $344.4K | +$86.3K (+33.4%) |
New holders (4)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 36,209 | $124.2K | 0.01% |
| Connective Capital Management, LLC | 28,600 | $98.1K | 0.09% |
| FNY Investment Advisers, LLC | 17,500 | $60.0K | 0.02% |
| United Financial Planning Group LLC | 17 | $58 | 0.00% |
Sold out (4)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Virtu Financial LLC | 18,808 | $69.0K |
| Alpine Global Management, LLC | 16,351 | $59.7K |
| Susquehanna International Group, LLP | 10,156 | $37.1K |
| Raymond James Financial Inc | 1 | $4 |